Chip mutations mediate human atherosclerosis by activating monocyte pro-inflammatory pathways without evidently promoting monocyte chemotaxis. (August 2021) - Dederichs, T.-S.; Ehlert, C.; Becker, H.; Pfeifer, D.; Bode, C.; Hilgendorf, I.